We are live on
!
Find out more
US Bancorp Portfolio holdings
AUM
$82.4B
1-Year Est. Return
19.69%
This Fund
S&P 500
This Quarter
Est. Return
+8.01%
1 Year Est. Return
+19.69%
3 Year Est. Return
+59.6%
5 Year Est. Return
+69.89%
10 Year Est. Return
+246.63%
AUM
$39.1B
AUM Growth
+$2.42B
(+6.6%)
Cap. Flow
-$248M
Cap. Flow
% of AUM
-0.63%
Top 10 Holdings %
Top 10 Hldgs %
22.64%
Holding
3,845
New
218
Increased
1,110
Reduced
1,483
Closed
148
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
iShares Russell Mid-Cap ETF
IWR
|
+$45.6M |
| 2 |
iShares Core MSCI EAFE ETF
IEFA
|
+$40.7M |
| 3 |
iShares Core S&P 500 ETF
IVV
|
+$38.8M |
| 4 |
iShares S&P 500 Value ETF
IVE
|
+$35.5M |
| 5 |
Bristol-Myers Squibb
BMY
|
+$34.1M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
CELG
Celgene Corp
CELG
|
+$80.2M |
| 2 |
Copart
CPRT
|
+$55.9M |
| 3 |
US Bancorp
USB
|
+$47.8M |
| 4 |
IBDK
iShares iBonds Dec 2019 Term Corporate ETF
IBDK
|
+$25.8M |
| 5 |
iShares Floating Rate Bond ETF
FLOT
|
+$17.3M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 11.27% |
| 2 | Financials | 10.78% |
| 3 | Industrials | 9.91% |
| 4 | Healthcare | 9.19% |
| 5 | Consumer Staples | 6.67% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
1526
Thor Industries
THO
$3.99B
| $364K | ﹤0.01% |
4,909
-822
| -14% | -$53K |
|
|
EMO
1527
ClearBridge Energy Midstream Opportunity Fund
EMO
$1.06B
| $363K | ﹤0.01% |
8,630
-8,393
| -49% | -$343K |
|
1528
West Bancorporation
WTBA
$464M
| $363K | ﹤0.01% |
14,155
+9,388
| +197% | +$223K |
|
|
MDP
1529
DELISTED
Meredith Corporation
MDP
| $363K | ﹤0.01% |
11,188
+2,188
| +24% | +$77.8K |
|
1530
ICF International
ICFI
$1.44B
| $362K | ﹤0.01% |
3,946
+2,896
| +276% | +$249K |
|
|
TBNK
1531
DELISTED
Territorial Bancorp Inc.
TBNK
| $362K | ﹤0.01% |
11,700
| – | – |
|
|
PGTI
1532
DELISTED
PGT, Inc.
PGTI
| $361K | ﹤0.01% |
24,174
-867
| -3% | -$13.8K |
|
1533
Voya Financial
VOYA
$8.94B
| $360K | ﹤0.01% |
5,907
+4,247
| +256% | +$240K |
|
1534
Regency Centers
REG
$15B
| $358K | ﹤0.01% |
5,680
-5,552
| -49% | -$365K |
|
1535
Ashland
ASH
$3.04B
| $357K | ﹤0.01% |
4,665
-41
| -0.9% | -$3.11K |
|
1536
KKR & Co
KKR
$89.2B
| $357K | ﹤0.01% |
12,253
+183
| +2% | +$5.21K |
|
|
NXRT
1537
NexPoint Residential Trust
NXRT
$665M
| $357K | ﹤0.01% |
7,936
+2,003
| +34% | +$94.3K |
|
1538
Novanta
NOVT
$5.04B
| $356K | ﹤0.01% |
4,021
+113
| +3% | +$9.75K |
|
1539
WSFS Financial
WSFS
$4.1B
| $356K | ﹤0.01% |
8,087
+4,468
| +123% | +$195K |
|
|
CXO
1540
DELISTED
CONCHO RESOURCES INC.
CXO
| $356K | ﹤0.01% |
4,061
-319
| -7% | -$23K |
|
1541
Marten Transport
MRTN
$1.33B
| $355K | ﹤0.01% |
24,788
-24,510
| -50% | -$350K |
|
1542
Prestige Consumer Healthcare
PBH
$2.35B
| $354K | ﹤0.01% |
8,735
+1,795
| +26% | +$67K |
|
1543
Dr. Reddy's Laboratories
RDY
$9.82B
| $354K | ﹤0.01% |
43,560
-2,165
| -5% | -$17.1K |
|
1544
Acadia Healthcare
ACHC
$3.17B
| $352K | ﹤0.01% |
10,616
+5,033
| +90% | +$158K |
|
1545
GDS Holdings
GDS
$6.34B
| $351K | ﹤0.01% |
6,805
-88
| -1% | -$3.94K |
|
1546
VictoryShares US Large Cap High Div Volatility Wtd ETF
CDL
$404M
| $349K | ﹤0.01% |
6,902
-640
| -8% | -$31.3K |
|
1547
Uber
UBER
$134B
| $349K | ﹤0.01% |
11,755
+5,387
| +85% | +$160K |
|
1548
MGIC Investment
MTG
$6.27B
| $348K | ﹤0.01% |
24,498
+3,966
| +19% | +$55K |
|
|
DRE
1549
DELISTED
Duke Realty Corp.
DRE
| $348K | ﹤0.01% |
10,039
+185
| +2% | +$6.39K |
|
1550
Blackbaud
BLKB
$1.5B
| $347K | ﹤0.01% |
4,353
+289
| +7% | +$24.2K |
|
Similar funds
US Bancorp's Q4 2019 Portfolio in Review
As of Q4 2019, US Bancorp held 3,845 positions worth $39.1B, up 6.6% from $36.7B the previous quarter. Its ten largest holdings account for 23% of the portfolio.
US Bancorp's Q4 2019 filing shows 218 new, 1,110 increased, 1,483 reduced and 148 closed positions. Its largest new stake was Bristol-Myers Squibb Company Contingent Value Rights: 611,031 shares worth $1.84M. The largest sale was Celgene Corp, an estimated $80.2M.
By sector, the portfolio is most concentrated in Technology at 11% of assets, up from 11% a quarter earlier, followed by Financials and Industrials.
- US Bancorp's largest Q4 2019 buy was Bristol-Myers Squibb Company Contingent Value Rights: 611,031 shares worth $1.84M.
- US Bancorp added most to iShares Russell Mid-Cap ETF in Q4 2019, an estimated $45.6M increase.
- US Bancorp's biggest Q4 2019 reduction was Copart, cutting an estimated $55.9M.
- US Bancorp fully exited Celgene Corp in Q4 2019, selling an estimated $80.2M.
- US Bancorp's ten largest holdings make up 23% of its $39.1B portfolio in Q4 2019.
- US Bancorp opened 218 new positions and closed 148 in Q4 2019.
- US Bancorp's portfolio value rose 6.6% quarter-over-quarter to $39.1B.
Based on US Bancorp's 13F filing for Q4 2019, filed 4 Feb 2020.